Solano Pharmaceuticals
2013
FOUNDED
PRIVATE
STATUS
Grant
LATEST DEAL TYPE
$226K
LATEST DEAL AMOUNT
1
INVESTORS
Description
Owner and operator of a biopharmaceutical company. The company develops a class of mitochondrial-targeted antioxidants for the treatment of neurodegenerative diseases.
Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Primary Office
- 820 Heinz Avenue
- Berkeley, CA 94710
- United States
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Solano Pharmaceuticals’s full profile, request a free trial.
Solano Pharmaceuticals Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Grant | 15-Jun-2014 | $226K | Completed | Startup | ||
| 1. Accelerator/Incubator | Completed | Startup |
Solano Pharmaceuticals Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| California Institute for Quantitative Biosciences | Accelerator/Incubator | 000 0000 | 000000 0 |